Schwartz is a seasoned executive with more than two decades of experience in a range of finance roles at health tech and financial services organizations. She joins Resmed from Illumina, Inc., where ...

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will ...

In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look ...

ResMed Inc. closed 18.65% short of its 52-week high of $263.05, which the company reached on January 30th.

ResMed Inc. closed 19.96% below its 52-week high of $263.05, which the company achieved on January 30th.

Piper Sandler lifted their price target on ResMed from $252.00 to $260.00 and gave the company a “neutral” rating in a research note on Friday, January 31st. Finally, KeyCorp upped their price ...

ResMed RMD shares rallied 3.8% in the last trading ... In the last reported quarter, the company achieved robust revenue growth across all product and geographic categories. Additionally, market ...

Piper Sandler increased their target price on ResMed from $252.00 to $260.00 and gave the company a “neutral” rating in a research report on Friday, January 31st. The Goldman Sachs Group ...

Joey Jordison ’s family have shared the drummer’s original design of the Slipknot logo.

In this article, we are going to take a look at where ResMed Inc. (NYSE:RMD stands against other stocks that Jim Cramer discussed recently. Jim Cramer, host of Mad Money, warned investors on ...